These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32014689)

  • 1. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
    Kiyonaga N; Moriyama T; Kanmura Y
    Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats.
    Fu C; Dai X; Yang Y; Lin M; Cai Y; Cai S
    Mol Med Rep; 2017 Jan; 15(1):131-138. PubMed ID: 27959438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
    Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
    Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
    Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
    J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
    Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Landiolol in Lipopolysaccharide-Induced Acute Kidney Injury in Rats and In Vitro.
    Kiyonaga N; Moriyama T; Kanmura Y
    Shock; 2019 Nov; 52(5):e117-e123. PubMed ID: 30585987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
    Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
    Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
    Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
    Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
    Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine alleviates pulmonary edema through the epithelial sodium channel (ENaC) via the PI3K/Akt/Nedd4-2 pathway in LPS-induced acute lung injury.
    Jiang Y; Xia M; Xu J; Huang Q; Dai Z; Zhang X
    Immunol Res; 2021 Apr; 69(2):162-175. PubMed ID: 33641076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
    Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
    J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pretreatment with dexmedetomidine ameliorates renal inflammation and oxidative stress in rats with lipopolysaccharide-induced sepsis and acute kidney injury].
    Chen YJ; Gong CL; Tan F; Zhou SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1472-5. PubMed ID: 26547344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
    Xiang H; Hu B; Li Z; Li J
    Inflammation; 2014 Oct; 37(5):1763-70. PubMed ID: 24803295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model.
    Qiu R; Yao W; Ji H; Yuan D; Gao X; Sha W; Wang F; Huang P; Hei Z
    Life Sci; 2018 Jul; 204():1-8. PubMed ID: 29733849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine preconditioning inhibits the long term inflammation induced by renal ischemia/reperfusion injury in rats.
    Liu G; Song H; Qiu L; He A; Tong F; Wan Q; Wang X; Xia Y; Huang L
    Acta Cir Bras; 2016 Jan; 31(1):8-14. PubMed ID: 26840350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
    Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
    Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity
    Zhou BY; Yang J; Luo RR; Sun YL; Zhang HT; Yang AX; Zhang GX
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):323. PubMed ID: 38179733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of anisodamine hydrobromide on lipopolysaccharide-induced acute kidney injury.
    Wan F; Du X; Liu H; He X; Zeng Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32573678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
    Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
    Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.